Image from Google Jackets

Immunotherapy for Pediatric Malignancies / edited by Juliet C. Gray, Aurélien Marabelle.

Contributor(s): Gray, Juliet C., editor literario | Marabelle, Aurélien., editor literario
Material type: materialTypeLabelE-bookSeries: (Medicine (Springer-11650)).Publisher: Cham : Springer International Publishing, 2018Description: 1 recurso en línea (IX, 297 páginas 29 ilustraciones, 27 ilustraciones a color).ISBN: 9783319434865.Subject: Oncología | Cáncer en niños | ImmunoterapiaOnline resources: Acceso a este recurso digital (usuarios Universidad Europea de Madrid)Digital Resources
Contents:
Introduction to Pediatric Cancer Immunotherapy -- Overcoming immune suppression in the tumor microenvironment: Implications for multi-modal therapy -- Allogeneic stem cell transplantation -- Overview of monoclonal antibody therapies -- Monoclonal Antibodies Targeting Hematological Malignancies -- Monoclonal Antibodies Directly Targeting Antigens on Solid Tumours -- Monoclonal antibodies targeting the immune system -- Adoptive T Cell Therapies for Children's Cancers -- NK Cell and NKT Cell Immunotherapy -- Cancer Vaccines in Pediatrics -- Immune Adjuvants and Cytokine Therapies -- Immune biomarkers in pediatric malignancies -- Future perspectives.
Abstract: This book provides a comprehensive overview of current immunotherapy strategies, and how these may be applicable to childhood cancers. The first part of the book reviews how the immune system recognizes cancer, and the various escape mechanisms allowing tumour growth. The importance of the tumor microenvironment and the challenges this may present to achieving effective immunotherapy are discussed. Monoclonal antibodies, cellular, cytokine and vaccine therapies are all comprehensively reviewed, with particular focus on their potential application to pediatric cancers. Practical aspects of delivering such therapies to children, likely toxicities and potential biomarkers are considered. Finally, consideration is given to how, in the longer term, such therapies may be combined with conventional therapies such as chemotherapy and radiotherapy. Edited by two distinguished pediatric oncologists with a collection of chapters from the most authoritative experts in cancer immunotherapy, this is an indispensable volume for pediatric oncologists and physicians working in childhood cancer care.
Tags from this library: No tags from this library for this title. Log in to add tags.
Star ratings
    Average rating: 0.0 (0 votes)
Holdings
Item type Current library Collection Call number Status Date due Barcode Item holds
LIBRO-E NO PRÉSTAMO LIBRO-E NO PRÉSTAMO Madrid Digital Acceso Electrónico (UEM) Ciencias de la Salud RC271.I45 I468 2018 EB (Browse shelf(Opens below)) Acceso electrónico eBook.08112505
Total holds: 0

Introduction to Pediatric Cancer Immunotherapy -- Overcoming immune suppression in the tumor microenvironment: Implications for multi-modal therapy -- Allogeneic stem cell transplantation -- Overview of monoclonal antibody therapies -- Monoclonal Antibodies Targeting Hematological Malignancies -- Monoclonal Antibodies Directly Targeting Antigens on Solid Tumours -- Monoclonal antibodies targeting the immune system -- Adoptive T Cell Therapies for Children's Cancers -- NK Cell and NKT Cell Immunotherapy -- Cancer Vaccines in Pediatrics -- Immune Adjuvants and Cytokine Therapies -- Immune biomarkers in pediatric malignancies -- Future perspectives.

This book provides a comprehensive overview of current immunotherapy strategies, and how these may be applicable to childhood cancers. The first part of the book reviews how the immune system recognizes cancer, and the various escape mechanisms allowing tumour growth. The importance of the tumor microenvironment and the challenges this may present to achieving effective immunotherapy are discussed. Monoclonal antibodies, cellular, cytokine and vaccine therapies are all comprehensively reviewed, with particular focus on their potential application to pediatric cancers. Practical aspects of delivering such therapies to children, likely toxicities and potential biomarkers are considered. Finally, consideration is given to how, in the longer term, such therapies may be combined with conventional therapies such as chemotherapy and radiotherapy. Edited by two distinguished pediatric oncologists with a collection of chapters from the most authoritative experts in cancer immunotherapy, this is an indispensable volume for pediatric oncologists and physicians working in childhood cancer care.

There are no comments on this title.

to post a comment.